Can Pilocarpine Eyedrops for Presbyopia Help You See Clearly Now?

The FDA recently approved the first eyedrop to treat age-related nearsightness due to poor accommodation, a disorder experienced by more than 100 million Americans. Spoiler alert . . . its pilocarpine eye drops -  which have been on the market for over 70 years.  What does the data say about this new formulation of an old drug and its ability to help with age-related presbyopia? Listen in for a discussion on efficacy and cost.Redeem your CPE or CME credit here!Pharmacist membersCMENeed a membership?Join for CPE Credit Join for CME Credit References and resources: https://www.ophthalmologytimes.com/view/fda-approves-eye-drops-for-treatment-of-presbyopiahttps://clinicaltrials.gov/ct2/show/NCT04657172Continuing Education Information:Learning Objectives: Describe the evidence that informed the FDA's decision to approve a new formulation of pilocarpine for presbyopia0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-040-H01-PInitial release date: 01/10/22Expiration date: 01/10/2023Additional CPE & CME details can be found hereFollow CEimpact on Social Media:LinkedInInstagram